EN
HI
Kabra Drugs Share price
KABRADG
19.98
0.17 (0.86%)Last updated on 20 Oct, 2025 | 15:29 IST
BUYSELL
Today's High
20.25
Today's Low
19.00
52 Week Low
9.14
52 Week High
22.77
The current prices are delayed, login to your account for live prices
LoginKabra Drugs Share Key Metrics
Volume
1.17 L
Market Cap
46.97 CR
LTQ@LTP
1@19.98
ATP
19.92
Var Margin
53.5 %
Circuit Range
18.82-20.8
Delivery %
0 %
Value
23.26 L
ASM/GSM
No
Market Lot
1
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
37.42
Sector P/B
3.53
Sec. Div. Yield
0.55
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-11-04 | Others |
| 2024-08-14 | Quarterly Results |
Kabra Drugs News
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
Kabra Drugs Similar Stocks
Unjha Formulations Ltd.
24.80
0.78 (3.25%)
Gian Life Care Ltd.
13.32
0.33 (2.54%)
Hindustan Bio Sciences Ltd.
8.99
0.74 (8.97%)
Decipher Labs Ltd.
10.00
0.27 (2.77%)
Ortin Global Ltd.
11.51
-0.04 (0.35%)
Dhanvantri Jeevan Rekha Ltd.
23.80
-0.07 (0.29%)
Dr Lalchandani Labs Ltd.
22.49
0.00 (0.00%)
Transpact Enterprises Ltd.
236.10
0.00 (0.00%)
MPS Pharmaa Ltd.
2.07
0.00 (0.00%)
Kobo Biotech Ltd.
2.74
0.11 (4.18%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 19.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 37.42 & 3.53 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 46.97 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 22.77 & 9.14. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.